no script no facebook ... not the end of the world.
Chart for article 'Will This Biotech Stock Join the $1,000 Human Genome Club in Early ...'
Is this chart helpful to you?
Publisher logo for The Motley Fool 2018

Will This Biotech Stock Join the $1,000 Human Genome Club in Early ...

SOURCE ARTICLE:
Will This Biotech Stock Join the $1,000 Human Genome Club in Early ...

Pacific Biosciences thinks platform upgrades will cut its Sequel machines' DNA sequencing costs 92% by 2019, opening a $2.5 billion market opportunity in 2022.

Related Charts